- $10.01bn
- $8.25bn
- $2.65bn
U.S. RESEARCH ROUNDUP-Dollar General, Palo Alto, Workday
Lawsuit against Bristol Myers over delayed cancer drug is revived (updated)
Lawsuit against Bristol Myers over delayed cancer drug is revived
UMB Financial Corp reports results for the quarter ended June 30 - Earnings Summary
UMB Financial Q2 revenue rises on loan growth, fee income
Brief: UMB Financial Q2 Net Income USD 277.57 Million
U.S. RESEARCH ROUNDUP-East West Bancorp, First Citizens Bancshares, UMB Financial
U.S. RESEARCH ROUNDUP- Dow, Palo Alto Networks, Zions Bancorporation
UMB Financial Q1 adjusted EPS beats estimates, revenue rises 31%
Brief: UMB Financial Q1 Adjusted EPS USD 4.76 Vs. IBES Estimate USD 2.8
U.S. RESEARCH ROUNDUP- AGNC Investment, Brown & Brown, Korro Bio
UMB Financial Q4 adjusted EPS beats estimates
Brief: UMB Financial Q4 Adjusted EPS USD 4.31 Vs. IBES Estimate USD 2.55
Bristol Myers drops after US judge rules co must face $6.7 bln lawsuit
UMB Financial Q3 adjusted EPS beats estimates on record loan production
Brief: UMB Financial Q3 Adjusted EPS USD 3.84 Vs. IBES Estimate USD 2.42
Brief: Umb Healthcare Services Completes Acquisition Of Health Savings Account Portfolio From Old National Bank
Brief: UMB Financial Corp To Redeem 3.70% Subordinated Notes Due 2030
Corrected: BRIEF-UMB Financial Received Shares Of Voyager Technologies Post-IPO